Bioventus Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	568.09	573.28	512.35	512.12	430.9
Revenue Growth (YoY)	-0.91%	11.89%	0.04%	18.85%	34.17%
Cost of Revenue	179.93	185.05	184.15	181.04	128.19
Gross Profit	388.16	388.23	328.19	331.08	302.71
Selling, General & Admin	314.03	343.8	303.88	332.13	254.25
Research & Development	12.11	13.95	13.45	23.85	19.04
Other Operating Expenses	2.32	38.02	83.75	132.58	8.99
Total Operating Expenses	328.46	395.77	401.08	488.57	282.28
Operating Income	53.98	-15.2	-81.73	-167.23	12.06
Interest Expense	-26.49	-38.79	-40.68	-12.02	-1.11
Other Non-Operating Income (Expense)	-27.14	-38.79	-40.68	-12.02	-1.11
Total Non-Operating Income (Expense)	-53.62	-77.58	-81.35	-24.04	-2.22
Pretax Income	25.71	-52.34	-121.11	-189.03	9.49
Provision for Income Taxes	-1.57	-5.29	0.09	-44.37	-1.97
Net Income	22.73	-36.13	-156.23	-158.7	19.38
Minority Interest in Earnings	4.54	-10.92	-39.4	-54.69	-9.79
Earnings From Discontinued Operations	-	-	74.43	68.74	1.87
Net Income to Common	22.73	-36.13	-156.23	-158.7	19.38
Net Income Growth	-	-	-	-	18.06%
Shares Outstanding (Basic)	67	65	63	61	45
Shares Outstanding (Diluted)	69	65	63	61	45
Shares Change (YoY)	6.77%	3.03%	2.05%	35.00%	-11.70%
EPS (Basic)	0.34	-0.56	-2.49	-2.59	-0.15
EPS (Diluted)	0.33	-0.56	-2.49	-2.59	-0.15
Shares Outstanding	67.1	65.76	63.27	62.06	59.55
Free Cash Flow	72.11	37.79	7.98	-15.02	9.47
Free Cash Flow Growth	90.83%	373.43%	-	-	-82.85%
Free Cash Flow Per Share	1.05	0.59	0.13	-0.24	0.21
Gross Margin	68.33%	67.72%	64.06%	64.65%	70.25%
Operating Margin	9.50%	-2.65%	-15.95%	-32.66%	2.80%
Profit Margin	9.60%	-16.41%	-61.84%	-69.91%	4.88%
FCF Margin	12.69%	6.59%	1.56%	-2.93%	2.20%
EBITDA	100.99	34.36	-24.36	-111.84	46.94
EBITDA Margin	17.78%	5.99%	-4.75%	-21.84%	10.89%
EBIT	53.98	-15.2	-81.73	-167.23	12.06
EBIT Margin	9.50%	-2.65%	-15.95%	-32.66%	2.80%
Effective Tax Rate	-6.09%	10.11%	-0.07%	23.48%	-20.72%

Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q